...
首页> 外文期刊>Case Reports in Ophthalmology >Choroidal Neovascularization Associated with Punctate Inner Choroidopathy: Combination of Intravitreal Anti-VEGF and Systemic Immunosuppressive Therapy
【24h】

Choroidal Neovascularization Associated with Punctate Inner Choroidopathy: Combination of Intravitreal Anti-VEGF and Systemic Immunosuppressive Therapy

机译:脉状新生血管与点状内脉络膜病变:玻璃体内抗VEGF和全身免疫抑制治疗的组合。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: Choroidal neovascularization (CNV) associated with punctate inner choroidopathy (PIC) is a rare clinical entity, yet still a challenge for medical treatment. A case of a young myopic woman developing CNV secondary to unilateral PIC is presented. Clinical morphology, diagnostic procedure and follow-up are reported. Case Report: A 29-year-old woman presented with multiple yellowish dots at the posterior pole. No other signs of inflammation could be seen. Angiography with fluorescein yielded hyperfluorescent signals in the affected areas with a diffuse leak, and SD-OCT showed a slightly elevated retinal pigment epithelial layer, consistent with the diagnosis of PIC. Additionally a classic CNV was observed. Results: Anti-inflammatory therapy with local prednisolone acetate eye drops in combination with intravitreal injection of anti-vascular endothelial growth factor (VEGF, bevacizumab) yielded an increased best-corrected visual acuity. As CNV reappeared, systemic medication with prednisone and azathioprine in combination with two further intravitreal injections of anti-VEGF stabilized CNV and increased visual acuity again. Conclusion: Combined therapy of immunosuppression with intravitreal anti-VEGF injections can be considered as therapeutic strategy in the management of recurrent CNV associated with PIC.
机译:目的:与点状内脉络膜病变(PIC)相关的脉络膜新生血管形成(CNV)是一种罕见的临床实体,但仍是药物治疗的挑战。介绍了一名年轻的近视女性继发于单侧PIC的CNV。报告了临床形态,诊断程序和随访。病例报告:一名29岁妇女在后极处出现多个淡黄色斑点。没有其他炎症迹象。血管造影术在受影响的区域产生荧光信号,并伴有弥漫性渗漏,SD-OCT显示视网膜色素上皮层略微升高,与PIC的诊断一致。另外,观察到经典的CNV。结果:局部醋酸泼尼松龙滴眼液联合玻璃体内注射抗血管内皮生长因子(VEGF,贝伐单抗)进行的抗炎治疗产生了最佳矫正视力。随着CNV的出现,与泼尼松和硫唑嘌呤联合两次玻璃体内注射抗VEGF的全身药物稳定了CNV,并再次提高了视力。结论:免疫抑制联合玻璃体内注射抗VEGF可以被认为是治疗与PIC相关的CNV复发的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号